Related Experiment Video

Updated: May 14, 2025

Assaying the Kinase Activity of LRRK2 in vitro
06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

22.5K

The Multifaceted Role of LRRK2 in Parkinson's Disease

Dong Hwan Ho1, Sun Jung Han2, Ilhong Son1,2

  • 1InAm Neuroscience Research Center, Wonkwang University Sanbon Medical Center, 321, Sanbon-ro, Gunpo-si 15865, Gyeonggi-do, Republic of Korea.

Brain Sciences
|May 1, 2025
PubMed

Insights

Leucine-rich repeat kinase 2 (LRRK2) is crucial in neurodegenerative diseases like Parkinson's. Its roles in mitochondria, inflammation, and astrocyte function present therapeutic opportunities.

Area of Science:

  • Neurobiology
  • Molecular Medicine

Background:

  • Leucine-rich repeat kinase 2 (LRRK2) is a protein kinase implicated in neurodegenerative diseases, notably Parkinson's disease (PD).
  • LRRK2 influences critical cellular processes including mitochondrial function, autophagy, oxidative stress, and protein aggregation.

Purpose of the Study:

  • To elucidate the multifaceted roles of LRRK2 in cellular senescence, neuroinflammation, and neuronal development.
  • To highlight LRRK2's significance as a therapeutic target for neurodegenerative disorders.

Main Methods:

  • Review of existing literature on LRRK2's molecular and cellular functions.
  • Analysis of LRRK2's involvement in key pathways relevant to neurodegeneration.

Main Results:

  • LRRK2 regulates mitochondrial health, cellular senescence, and ciliogenesis.
  • LRRK2 modulates neuroinflammation by affecting microglia and cytokine production.
  • LRRK2 mutations impact neurotrophic factor production in astrocytes, affecting neuronal health.

Conclusions:

  • LRRK2's diverse functions in cellular senescence, mitochondria, neuroinflammation, and astrocyte activity underscore its importance in PD pathogenesis.
  • Targeting LRRK2 offers potential therapeutic strategies for neurodegenerative diseases.
Keywords:
Parkinson’s diseasecellular senescenceciliogenesisleucine-rich repeat kinase 2mitochondrial homeostasisneuroinflammationneurotrophic factortranslation

More Related Videos

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

14.9K
Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate11:31

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

9.9K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
334
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
158
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.3K